Jill Carroll

Jill is a Partner at S.R. One. Previously, Jill’s background is in corporate development and partnering in biotech companies, including Dynavax Technologies (NASDAQ: DVAX). Jill also worked as a consultant, specializing in health care. Jill is a member of the Board of Directors of HotSpot Therapeutics, Pandion Therapeutics and Second Genome. Jill received her B.S. from Duke University and her M.S. in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University.